HCPCS J-code
J2778: ranibizumab
Ranibizumab 0.1 mg (anti-VEGF, AMD)
Code
J2778
Generic
ranibizumab
Brands
Lucentis
Drug class
Biologic drugs (mAbs and biosimilars)
Common denial patterns
- Biosimilar preferred
Frequently asked questions
What is HCPCS J2778?
Ranibizumab 0.1 mg (anti-VEGF, AMD)
Why does insurance commonly deny J2778?
Biosimilar preferred.
What brand-name drug uses J2778?
Lucentis.
Related
Appeal a J2778 denial
Upload the denial — we draft the appeal letter in 5 minutes citing the right clinical guideline.
Get started →Contact: hello@approvalhelp.com